Chapter 22: Cancer pain assessment and management
Skip chapter table of contents and go to main content
Cancer pain assessment and management
Pain assessment
Evidence‐based approaches
Pain is a common symptom in patients with cancer (Chapman [35]). Causes of cancer pain can be multifactorial and are related to either the effects of cancer treatment such as surgery, radiotherapy or chemotherapy, or pain can be caused by the cancer itself such as in patients with bone metastases or where the cancer has caused injury to nerves. Cancer pain can be both acute and chronic and requires careful assessment and attention to detail, including a detailed history of previously tried medications and responses to these pharmacological interventions. Assessment, treatment plan and review are key to the management of cancer pain.
Methods of pain assessment
Cancer pain is multidimensional and complex and therefore a comprehensive and holistic assessment is essential in formulating an effective management plan (Burton et al. [31]). Cancer pain may change depending on disease progression and response to treatment; it is complex and as stated previously can be a mix of acute treatment‐related episodes alongside chronic disease‐related pathways. Pain assessment is not a one‐off episode, pain is dynamic and changes, and therefore pain assessment should be dynamic in order to ensure the appropriate management strategy is in place.
Total pain
The term ‘total pain’ was first used by Dame Cicely Saunders ([199]) with the aim of identifying the impact that pain has on the individual as a whole. Dame Cicely suggested that pain is influenced by psychological, social, emotional and spiritual factors that contribute to the individual's overall pain experience. The physical aspects of the pain could be a result of treatment side‐effects or caused by the cancer itself; psychological factors that will heighten perception of pain are anxiety, depression and previous episodes of poorly controlled pain; social aspects can be loss of income due to ill health and financial concerns; and spiritual factors can be loss of faith, fear of the unknown and loss of meaning/purpose (IASP [108]). It is for this reason that pain assessment must be multidimensional and holistic in order to address the needs of the patient.
Assessment tools
A variety of assessment tools have been validated for use in clinical practice.
- One‐dimensional tools are effective in monitoring pain intensity (Hjermstad et al. [99]). These are most commonly used in acute pain as they are a quick and convenient method of assessing pain at the bedside and allow us to quantify baseline pain scores that can be used to assess response to treatment (Chapman [35]).
- Multidimensional tools are used to measure the patient's overall pain experience. Given that cancer pain is complex and multidimensional, these tools can be more effective in performing a comprehensive pain assessment.
One‐dimensional tools
The simplest techniques for pain measurement involve the use of a verbal rating scale, numerical rating scale or visual analogue scale. Patients are asked to match pain intensity to the scale. Three principles apply to the use of these scales:
- The patient must be involved in scoring his or her own pain intensity. It provides the patient with an opportunity to express their pain intensity and also what it means to them and the effect it has on their lives. This is important because healthcare professionals frequently underestimate the intensity of a patient's pain and effectiveness of pain relief (Alemdar and Aktas [2], Drayer et al. [56], Idvall et al. [105], Loveman and Gale [126]).
- Pain intensity assessment should incorporate different components of pain. It should include assessment of static (rest) pain and dynamic pain (on sitting, coughing or moving the affected part). For example, in a post‐operative patient this is important to prevent complications of delayed recovery such as chest infections and emboli (deep vein thrombosis, pulmonary embolism) and to determine if analgesia is adequate for return of normal function (Hobbs and Hodgkinson [100], Macintyre and Schug [128]).
- It is important to remember that a complete picture of a patient's pain cannot be derived solely from the use of a pain scale (Burton et al. [31]). Ongoing communication with the patient is required to uncover and manage any psychosocial factors that may be affecting the patient's pain experience.
Lim et al. ([124]) surveyed 551 patients on their satisfaction with pain assessment scales and found that 79% were in favour of using the scales and that they were beneficial in managing their pain symptoms.
Multidimensional tools
A variety of multidimensional assessment tools can be used to assess other aspects of cancer pain.
- The McGill Pain Questionnaire Short Form (1987) lists 15 descriptors of pain that the patient can then score as none, mild, moderate or severe. The terms used include throbbing, shooting, sharp, cramping. The multidimensional nature of this scale takes the form of four final descriptors of tiring – exhausting, sickening, fearful and punishing‐cruel – to assess the impact the pain experience is having on the patient as a whole. This is a quick and easy tool that can be utilized in a clinic setting (Ngamkham et al. [153]).
- The Brief Pain Inventory (BPI) (Cleeland and Ryan [40]) consists of three main sections:
- A front and back body diagram that allows the patient to mark the area of pain.
- Pain severity. Patients are asked to score pain using a 0–10 scale where 0 is no pain and 10 is most severe.c. Pain impact on daily function. Patients are asked to score the level of interference they are experiencing from pain where 0 is no interference and 10 is complete interference.The brief pain inventory is a widely used and validated method of pain assessment in both cancer patients and in a chronic pain population (Furler [80]).
- The MD Anderson Symptom Inventory (MDASI) (Cleeland et al. [41]) is based on the BPI and has been expanded on to include a variety of symptoms other than pain that impact the cancer population. The MDASI tool has been used to identify symptoms of pain, fatigue, nausea, disturbed sleep, emotional distress, shortness of breath, lack of appetite, drowsiness, dry mouth, sadness, vomiting, memory difficulties and numbness and tingling (Burton et al. [31]). On the same principles as the BPI, patients are asked to score the level of their symptoms based on a 0–10 scale with 0 being not present and 10 being the worst level imaginable. This comprehensive assessment tool allows the clinician to assess fully the impact of the patient's condition at the time and allow a review of multiple factors, not just pain.
Given the variety of assessment tools available it is important to find one that both the patient and the clinician understand and are able to use and engage with. It is important to understand that the patient's self‐reporting and classification of symptoms is more accurate than the clinician's perception of the patient's pain (Brunelli et al. [28]).
Pain assessment can be difficult to achieve. For example, the tendency suggested by both research and clinical practice is for the patient not to report any pain or to do so inadequately or inaccurately, minimizing the pain experience (Bell and Duffy [12], McCaffery and Beebe [138]). Nurses are influenced by a number of variables when assessing the amount of pain a patient is suffering (Kitson [118]). Pargeon and Hailey ([163]) demonstrated that healthcare providers usually over‐ or underestimate a patient's pain. McCaffery and Ferrell ([139]) found that nurses were more likely to accept a patient's report of pain if they were showing signs of visible distress than if they did not. It has also been suggested that nurses do not possess sufficient knowledge to care for patients in pain (Drayer et al. [56], McCaffery and Ferrell [139]). A survey of over 3000 nurses (McCaffery and Robinson [141]) demonstrated that nurse education has improved confidence in the pain assessment process but that further education continues to be required in the pharmacology of pain medications and addressing nurses’ fears of opioid addiction and respiratory depression, which continue to contribute to the undertreatment of pain.
A variety of pain assessment tools exist to assist nurses to assess pain and plan nursing care. They enable pain to be successfully assessed and monitored (McCaffery and Beebe [138], Twycross et al. [219], Walker et al. [229]) and improve communication between staff and patients (Raiman [179]). Higginson ([98], p. 150) notes that: ‘Taking assessments directly from the patient is the most valid way of collecting information on their quality of life’. Encouraging patients to take an active role in their pain assessment by using pain tools helps to increase their confidence and makes them feel part of the pain management process. It is important to remember that pain is whatever the patient reports it is at that time. However McCaffery and Ferrell ([139]) found that less than half of nurses surveyed agreed that patients’ self‐reporting of pain was reliable.
Some degree of caution, however, must be exercised with the use of pain assessment tools. The nurse must be careful to select the tool that is most appropriate for a particular type of pain experience: for example, it would not be appropriate to use a pain assessment tool designed for use with patients with chronic pain to assess post‐operative pain. Furthermore, pain tools should not be used indiscriminately. Walker et al. ([229]) found that pain tools appeared to have little value in cases of unresolved or intractable pain.
Accurate pain assessment and reassessment are crucial to develop an understanding and baseline measure of the pain. The role of the nurse is crucial in the assessment and management of the patient's pain as they spend the most time with the patient. The key is to ask appropriate questions, which should seek to cover the following areas. The SOCRATES pain assessment framework is a mnemonic commonly used by healthcare professionals.
- S – severity: none, mild, moderate, severe
- O – onset: when and how did it start?
- C – characteristic: is it shooting, burning, aching – ask the patient to describe it
- R – radiation: does it radiate anywhere else?
- A – additional factors: what makes it better?
- T – time: is it there all the time, is there a time of day when it is worse?
- E – exacerbating factors: what makes it worse?
- S – site: where is the pain?
In addition to this, questions relating to the following psychosocial elements should also be addressed (Mackintosh and Elson [130]).
- The effect of pain on mood.
- Are relationships affected by the pain?
- Physical limitations caused by the pain.
- Social effects: has the pain resulted in a loss of work or loss of role?
- Other types of pain affecting the patient.
- Previous treatments for pain and their effects.
- Other co‐morbidities.
- Allergies.
Neuropathic pain may require a specific assessment tool. Patients may describe spontaneous pain (arising without detectable stimulation) and evoked pain (abnormal responses to stimuli) (Bennett [13]). The Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) pain scale (Bennett [13]) was developed to more accurately assess this type of pain.
New UK National Guidelines to help healthcare professionals recognise and assess pain in older people have been published in 2018. The guidelines were developed by the British Geriatric Society, British Pain Society and Royal College of Nursing in collaboration with researchers. In adults with no or mild to moderate cognitive impairment, both numerical rating scales (0–10) and verbal descriptor rating scales (no pain, mild, moderate or severe pain) are reliable and valid for patients’ self‐report of pain intensity. The new UK guidelines include recognising that patient self‐reporting is the most reliable and accurate measure. Assessment may need to include the use of related terms such as ‘soreness, aching, or discomfort’ and also recommends that re‐wording questions to elicit the presence of pain such as ‘Do you hurt anywhere?’ can help to identify the presence or absence of pain (Schofield [200]). For older or vulnerable adults with moderate‐to‐severe cognitive/communication impairment Pain in Advanced Dementia (PAINAD) and Doloplus2 are recommended (Schofield [200]). Doloplus2 and PAINAD scales continue to show positive results in terms of reliability and validity. There has been no recent evaluation of the Abbey pain scale (Abbey et al. [1]) but it remains widely used throughout the UK due to its ease of use (Schofield [200]). Similarly, for patients who have a learning disability who cannot communicate their pain verbally, the use of pictorial or non‐verbal assessment tools may be appropriate and questioning those around the patient who know them well can be a great asset in assessing the pain needs of the person with a learning disability.
Fixed times for reviewing the pain have been omitted intentionally to allow for flexibility. It is suggested that, initially, the nurse review the patient's pain every 4 hours. When a patient's level of pain has stabilized, recordings may be made less frequently, for example 12‐hourly or daily. The chart should be discontinued if a patient's pain becomes totally controlled.